Philip Tinnefeld from LMU is coordinating a new doctoral training network at the interface of physics, chemistry, biology, and engineering.

LMU researchers have developed a novel cofactor that broadens the use of methyltransferases – with great potential for research and applications.

Chemists reveal method for differentiating PCET mechanisms – a key step for steering fundamental energy conversion and redox catalysis processes.

LMU scientist Olivia Merkel researches nanocarriers for the targeted delivery of drugs to their site of action. Now the company she co-founded, RNhale, has been awarded a lucrative EU grant to bring a new anti-asthma therapy to clinical readiness.